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1. Introduction 
Energy homeostasis is kept through a complex interplay of nutritional, neuronal and 
hormonal inputs that are integrated at the level of the central nervous system (CNS). A 
disruption of this regulation gives rise to life-threatening conditions that include obesity and 
type-2 diabetes, pathologies that are strongly linked epidemiologically and experimentally. 
The hypothalamus is a key integrator of nutrient-induced signals of hunger and satiety, 
crucial for processing information regarding energy stores and food availability. Much effort 
has been focused on the identification of hypothalamic pathways that control food intake 
but, until now, little attention has been given to a potential role for the hypothalamus in 
direct control of glucose homeostasis and nergy balance.  Recent studies have cast a new 
light on the role of the CNS in regulating peripheral glucose via a hypothalamic fatty acid 
(FA)-sensing device that detects nutrient availability and relays, through the autonomic 
nervous system, a negative feedback signal on food intake, insulin sensitivity and insulin 
secretion. Indeed, accumulating evidences suggest that FA are used in specific areas of CNS 
not as nutrients, but as cellular messengers which inform “FA sensitive neurons” about the 
energy status of the whole body (Blouet & Schwartz, 2010; Migrenne et al., 2006; Migrenne 
et al., 2011). Thus it has been described that up to 70% of hypothalamic arcuate nucleus 
(ARC) and ventromedian nucleus (VMN) neurons are either excited or inhibited by long 
chain fatty acids such as oleic acid (Jo et al., 2009; Le Foll et al., 2009; Migrenne et al., 2011). 
Within the VMN, 90% of the glucosensing neurons also have their activity altered by FA. In 
a large percentage of these neurons, glucose and FA have opposing effects on neuronal 
activity, much as they do on intracellular metabolism in many other cells (Randle et al., 
1994). Neuronal FA sensing mechanisms include activation of the KATP channel by long 
chain fatty acid acyl CoA (Gribble et al., 1998) or inactivation by generation of ATP or 
reactive oxygen species during mitochondrial ǃ-oxidation (Jo et al., 2009; Le Foll et al., 2009; 
Migrenne et al., 2011; Wang et al., 2006). Many fatty acid sensing neurons are activated by 
interaction of long chain fatty acids with the fatty acid transporter/receptor, FAT/CD36, 
presumably by activation of store-operated calcium channels by a mechanism that is 
independent of fatty acid metabolism (Jo et al., 2009). Importantly, most neurons utilize FA 
primarily for membrane production rather than as a metabolic substrate (Rapoport et al., 
2001; Smith & Nagura, 2001) and only nanomolar concentrations of fatty acid are required to 
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alter the activity of fatty acid sensing neurons in the absence of astrocytes (Jo et al., 2009). 
While cerebral lipids are both produced in the brain and transported into it from the 
periphery (Rapoport et al., 2001; Smith & Nagura, 2001), the mechanism of this transport 
and the actual levels of various FA in the extracellular space in the brain remains largely 
unknown. As mentioned above, hypothalamic FA sensing may be involved in the control of 
feeding behaviour, hepatic glucose production and insulin secretion. It seems also that 
intracellular FA metabolism is important to relay their effects (ǃ oxidation has been showed 
to be involved in oleate effect in hypothalamus) (Cruciani-Guglielmacci et al., 2004; Obici et 
al., 2003). In addition differential effect of FA in regard to feeding behaviour or glucose 
production may be related to their chain length and degree of saturation. For exemple, it has 
been showed in rodents that oleate both inhibits food intake and hepatic glucose production 
whereas octanoate has no effect on these parameters (Obici et al., 2002). In another study we 
showed that intracerebroventricular infusion of palmitate induced an hepatic insulin 
resistance and an impaired insulin signaling in hypothalamus (Benoit et al., 2009). In contrast 
oleate has no deleterious effect in this parameter (Benoit et al., 2009). Poly-unsaturated fatty 
acids (PUFA) such as n-3 or n-6 may have also different effects in neuronal activity and 
cognitive function such as memorization. The present work was aimed at studying differential 
effect of FA or triglycerides emulsion infused in rats in glucose homeostasis. In addition, in 
order to identify molecular mechanisms involved in specific effects of FA, mRNA expression 
of key genes involved in FA metabolism as well as ceramides and diacylglycerol (DAG) 
content have been measured in hypothalamus. Regarding physiopathology aspects it must be 
pointed out that dysfunction of central FA sensing could be a contributing factor to the early 
development of type 2 diabetes mellitus and/or obesity which leads to further dysfunction in 
predisposed subjects. A better understanding of these mechanisms, as well as further 
characterization of FA sensitive neurons and their role in physiological and pathological 
processes, might lead to identification of novel pharmacological targets for the prevention and 
treatment of diabetes and obesity. 
2. FA sensing in hypothalamus 
There is now growing amount of evidence suggesting, at least in rodents models, that some 
neurons located in hypothalamus (and brainstem) are sensitive to FA, ie their electrical 
activity is either increased or decreased in presence of variations of FA concentration. This 
has been evidenced both in vivo and in vitro. A key point is the transport of FA across the 
blood brain barrier (BBB). It cannot be excluded that FA may be produce directly in neurons 
from hydrolysis of intracellular troglycerides (TG). 
2.1 Transport of FA uptake into the brain and neurons 
Cerebral lipids are an essential component of both membranes and intracellular signalling 
pathways. They represent 50% of brain dry weight; the highest organ lipid content after 
adipose tissue (Edmond, 2001; Watkins et al., 2001). However, the mechanism by which FA 
are transported into the brain remains poorly understood. A growing body of evidence 
suggests that cerebral lipids are derived both from local synthesis and uptake from the 
blood (Rapoport et al., 2001). Several studies show that some poly-unsaturated FA (PUFA) 
have the ability to cross the BBB (Rapoport et al., 2001; Smith & Nagura, 2001). The question 
www.intechopen.com
 
Differential Effect of Fatty Acids in Nervous Control of Energy Balance 399 
of whether brain FA uptake occurs by passive diffusion or involves a protein which 
facilitates the transport is still matter of debate.  However, once across the BBB, it is likely 
that neurons can take up FA since some neurons do appear to have FA transporters. For 
example, dissociated neurons from the VMN of rats express mRNA’s for FA transport 
proteins (FATP)-1 and 4 and the FA transporter/receptor FAT/CD36 (Le Foll et al., 2009). 
Also, while it is unlikely that neurons derive much of their energy supply from FA, these 
same neurons do express mRNA’s for the intracellular metabolism of FA such as long chain 
acyl-CoA synthetase, carnitine palmitoyltransferase-1a and 1c and uncoupling protein-2 (Le 
Foll et al., 2009). They also express enzymes for de novo FA synthesis such as FA synthetase 
(Le Foll et al., 2009). But, it seems likely that much of the reported oxidation of FA such as 
palmitate in the brain probably occurs in astrocytes (Escartin et al., 2007) whereas other FA 
such as arachidonate are largely incorporated into phospholipids (Rapoport et al., 2001). 
2.2 Some hypothalamic neurons are lipid responsive 
The presence of neurons sensitive to variations in extracellular glucose levels is clearly 
demonstrated in the brain (Gilbert et al., 2003) and in particular in the hypothalamus 
(review in (Luquet & Magnan, 2009; Migrenne et al., 2011; Penicaud et al., 2002). Thirty-five 
years ago Oomura and colleagues first showed that FA activated lateral hypothalamic neurons 
which suggested a role for FA as neuronal signaling molecules (Oomura et al., 1975). As 
shown in Figure 1, FA also modify neuronal firing rate in hypothalamic arcuate nucleus (ARC) 
(Wang et al., 2006). Both FA “excited” (around 20% of arcuate neurons) and “inhibited” 
neurons (about 12%) are detected in arcuate nucleus of rat using this patch clamp technique 
(Wang et al., 2006). These FA sensitive neurons are also detected in vivo using multi-unit 
recording approaches (Wang et al., 2006). Therefore we demonstrated that single injection of 
oleic acid (OA) through carotid artery induced either increased or decreased neuronal activity 
depending on location of microelectrode in hypothalamus. It seems that some areas are mainly 
composed with FA “excited” neurons whereas others are mainly composed with FA 
“inhibited” neurons. Such data  also suggest that physiological variations of plasma FA 
concentrations (reflecting the metabolic state and energy availability) can be detected and 
integrated by FA sensing neurons in critical brain areas involved in the regulation of feeding 
behaviour, glucose and lipid metabolism (Clement et al., 2002; Obici et al., 2002). Indeed 
increased plasma FA concentration during fasted or starvation may be detected by FA excited 
neurons which in turn may have an impact on nervous control of energy balance. On the 
contrary decreased plasma FA concentration during a meal could be also detected by these 
sensitive neurons which may act a satiety signal like insulin and glucose do during a meal 
when acting on hypothalamus sensitive neurons (Gilbert et al., 2003). 
The physiological relevance of brain FA sensing is supported by various studies showing 
that local increases in brain and hypothalamic FA levels are associated with changes in 
insulin secretion and hepatic glucose output with variable effects on food intake (Clement et 
al., 2002; Obici et al., 2002; Ross et al., 2010; Schwinkendorf et al., 2010). For example, a 6 
hour intracerebroventricular (icv) infusion of the monounsaturated FA, oleic acid (OA), 
reduced food intake as well as hepatic glucose production (HGP) (Obici et al., 2002). 
Reducing hypothalamic FA oxidation by inhibition of carnitine palmitoyl transferase -1 
(CPT1), the enzyme that promotes ǃ-oxidation by facilitating transport of medium- and 
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long-chain FA into mitochondria, mimicked these effects on food intake and HGP induced 
by icv infusion of OA (Obici et al., 2003). In another study a direct bilateral infusion of OA 
into the mediobasal hypothalamus decreased hepatic glucose production (Ross et al., 2010). 
In addition, it seems that the hypothalamus differentially senses FA. For example, icv 
infusions of OA or docosahexanoic acid, but not palmitic acid, reduce food intake and body 
weight (Schwinkendorf et al., 2010). However, icv and direct infusions of FA into the brain 
are not physiological. Thus, they might produce non-specific effects by evoking an 
inflammatory response by irritating ependymocytes and tanycytes lining the ventricles or 




Fig. 1. Fragments of whole cell current clamp recordings of oleic acid (OA) excited (A) and 
inhibited (B) neuron in arcuate nucleus of rat (Adapted from Wang et al, 2006 et Migrenne et 
al, 2006).The inhibitory effect of OA on neuronal activity is inhibited by tolbutamide (C), 
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More physiological routes include elevating systemic levels of FA or infusing them directly 
into the carotid arteries, the major route by which FA reach the forebrain. For example, a two-
fold increase in plasma triglycerides produced by a two day systemic infusion of triglycerides 
was associated with decreased sympathetic activity. This reduced sympathetic tone, which is 
also produced by central FA infusions (Magnan et al., 1999), might contribute to the associated 
FA-induced exaggeration of glucose-induced insulin secretion (GIIS), a condition which is 
similar to what occurs in the prediabetic state (Magnan et al., 1999). Also, this exaggerated GIIS 
and a reduction in HGP were mimicked by infusing triglycerides into the carotid artery 
(Cruciani-Guglielmacci et al., 2004). These exaggerated responses were reduced by central 
inhibition CPT1 (Magnan et al., 1999). Similarly, central CPT1 inhibition was associated with 
an increase in the acyl CoA intracellular pool which was postulated to be the “final” satiety 
signal rather than FA themselves (review in (Lam et al., 2005; Luquet & Magnan, 2009). 
However, there are at least two potential problems involved in the interpretation of such in 
vivo data. First, the idea that increases in brain FA levels act as a satiety signal to inhibit 
feeding (Obici et al., 2003) is counterintuitive given the fact that plasma FA levels do not rise 
substantially after food ingestion, but do rise significantly during fasting (Ruge et al., 2009). 
Second, the vast majority of FA oxidation in the brain occurs in astrocytes rather than neurons 
(Escartin et al., 2007). While a select group of neurons in the hypothalamus clearly responds 
directly to changes in ambient FA levels by altering their activity (Le Foll et al., 2009; Oomura 
et al., 1975), only a relatively small percentage of these responses depend upon neuronal FA 
metabolism (Le Foll et al., 2009). Furthermore, although ǃ-oxidation and formation of malonyl-
CoA and FA metabolites such as acyl-CoA may be mediators of the in vivo effects produced 
by FA infusions (Dowell et al., 2005; Migrenne et al., 2011) it is likely that most of these occur at 
the level of the astrocyte. If so, then there must be a mechanism by which alterations in 
astrocyte FA metabolism can provide a signal to those neurons which regulate HGP and food 
intake. We suggest that this communication between astrocyte FA metabolism and neuronal 
FA sensing involves the production and export of ketone bodies from astrocytes (Escartin et 
al., 2007) and subsequent uptake by neurons. Finally another important issue is the nature of 
the FA and its effect on sensitive neurons. As previously mentioned OA and octanoate have 
differential effect regarding food intake or hepatic glucose production, suggesting that 
medium or long chain fatty acids may have different effects (Obici et al., 2002). Thus, the aim 
of the present study was to test whether different FA may have different effect on glucose 
homeostasis when infused in rats brains through carotid artery. Triglyceride emulsion either 
enriched in ω3, ω6 FA or saturated FA (lard oil) have been also tested. 
3. Methods 
All animal care and experimental procedures were approved by the animal ethics committee 
of the university Paris-Diderot. Four weeks-old male wistar rats were purchased from 
Charles Rivers (Lyon, France) and housed at 21°C with normal light/dark cycle and free 
access to water and food. 
3.1 First serie of experiments 
Rats received an intracerebroventricular (icv) infusion of FA during 3 days. Briefly, rats 
anesthetized with isoflurane were stereotactically implanted with a chronic stainless steel 
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cannula in the right lateral cerebral ventricle. The cannula was connected via a 
polyethylene catheter to a subcutaneously osmotic minipump filled up with FA (oleate, 
octanoate or linolenate) or saline. Infusions started 6h after surgery. The rate of infusion 
was 0.5 µl/h. Blood was daily removed (~ 80 µl) from caudal vessels for measurement of 
plasma substrate (FA and glucose) and insulin. Food intake was daily measured. At day 3 
of infusion glucose-induced insulin secretion (GIIS) was measured in response to a single 
intraperitoneal injection of glucose (0.5g/kg bw). was made in overnight fasted rats. The 
glycemia was determined by a glucometer (AccuChek, Rabalot, France) from 2 µl 
collected from the tip of the tail vein at time 0, 5, 10, 15, 20, 30 and 60 min. In addition 20 
µl of blood was sampled at the same time for insulin measurement (RIA, Diasorin, 
France). In another serie of experiments, etomoxir (CPT1 inhibitor) was concomitantly 
infused with FA. At the end of experiment brain were removed and five hypothalamus 
nuclei (arcuate, lateral, ventromedian, paraventricular and dorsomedian) were 
micropunched in order to measure gene expression (acetylCoA carboxylase, ACC, 
carnitine palmitoyl transferase, CPT1, FA synthase, FAS, G protein related peptide 
GPR41). Briefly, total RNA was isolated from the hypothalamus using RNeasy Lipid kit 
(Qiagen). To remove residual DNA contamination, the RNA samples were treated with 
DNAse RNAse-free (Qiagen). 4 µg of total RNA from each sample was reverse transcribed 
with 40 U of M-MLV Reverse Transcriptase (Invitrogen, life technologies) using  random 
hexamer primers. 
3.2 Second serie of experiments 
In a second serie of experiments our goal was to test the effect of different triglyceride 
emulsion on glucose tolerance and both diacylglycerol and ceramides content in 
hypothalamus. To that end rats received an intracarotid infusion during 24 h of lard oil, 
mainly composed of saturated FA (SFA), ω3-enriched (Omegaven, Santec, France) or ω6-
enriched (Ivelip, Rabalot, France) polyunsaturated FA (PUFA) triglyceride emulsion. The 
long-term unrestrained infusion technique was used, as previously described (Gilbert et al., 
2003). Briefly, 5 days before the beginning of the infusion, rats were anaesthetized with 
isoflurane for catheterization of right carotid artery, towards the brain. Catheter was then 
exteriorized at the vertex of the head, and animals were allowed to recover for 5 days. For 
infusion, catheter is connected to a swiveling infusion device, allowing the animal free 
access to water and food and infused with a triglyceride emulsion. Food intake was 
measured after the 24h infusion period. In another set of experiments, oral glucose tolerance 
test (3g/kg, OGTT) was also performed. 
3.3 Extraction and analysis of ceramids and DAG content in the hypothalamus 
Diacylglycerol and ceramide levels in tissues extracts were measured by the diacylglycerol 
kinase enzymatic method as previously described (Escalante-Alcalde et al., 2003; Le Stunff et 
al., 2002). Briefly, aliquots of the chloroform phases from cellular lipid extracts were re-
suspended in 7.5% (w/v) octyl-ǃ-D-glucopyranoside/5 mM cardiolipin in 1 mM 
DETPAC/10 mM imidazole (pH 6.6). The enzymatic reaction was started by the addition of 
20 mM DTT, 0.88 U/ml E. coli diacylglycerol kinase, 5 µCi/10 mM [-32P]ATP and the 
reaction buffer (100 mM imidazole (pH 6.6), 100 mM NaCl, 25 mM MgCl2, and 2 mM 
EGTA). After incubation for 1 h at room temperature, lipids were extracted with 
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chloroform/methanol/HCl (100:100:1, v/v) and 1 M KCl. [-32P]-phosphatidic acid was 
resolved by TLC with chloroform/acetone/methanol/acetic acid/water (10:4:3:2:1, v/v) 
and quantified with a Molecular Dynamics Storm PhosphorImager. Known amounts of 
diacylgycerol and ceramide standards were included with each assay. Ceramide and 
diacylglycerol levels were expressed as pmol by nmol of phospholipid (PL) levels. Total 
phospholipids present in cellular lipid extracts used for ceramide analysis were quantified 
as described previously (Escalante-Alcalde et al., 2003; Le Stunff et al., 2002) with minor 
modifications. Briefly, a mixture of 10N H2SO4/70% perchloric acid (3:1, v/v) was added to 
lipid extracts which were incubated for 30 min at 210°C. After cooling, water and 4.2% 
ammonium molybdate in 4 N HCl/0.045% malachite green (1:3 v/v) was added. Samples 
were incubated at 37°C for 30 min, and absorbance was measured at 660 nm. 
4. Results 
In the first serie of experiment, whatever the FA ie oleate or linolenate), there was no change 
in food intake during experiment (data not shown). Basal plasma glucose, FA, and insulin 
concentrations were also similar in all groups. As displayed in figure 2, in response to 
glucose load in linoleate group time course of glycemia was similar to control but was 
associated with an increased glucose induced insulin secretion (GIIS), suggesting an insulin 
resistance state which was compensated by this increased GIIS. In oleate infused group 
there was no change in plasma glucose or GIIS compared to controls. 
  
Fig. 2. Time course of plasma glucose and insulin concentration in response to glucose 
injection in oleate, linolenate,  and NaCl (controls) icv 24h  infused rats. **, p < 0.01 vs oleate 
and controls. 
In order to test whether ǃ oxidation was required to relay FA effect, GIIS was measured in 
presence or not of etomoxir a specifix inhibitor of CPT1 activity, a rate-limiting enzyme of ǃ 
oxidation (figure 3). Results are expressed as insulinogenic index (ie ratio of areas under the 
curve of insulin to glucose during GIIS). Effect of linolenate on GIIS was reversed by etomoxir. 
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Fig. 3. Insulinogenic index in control rats, oleate and linolenate infused rats with or without 
etomoxir, a specific inhibitor of CPT1.*** p<0.01 vs controls 
Hypothalamic gene expression have been measured in five areas (figure 4) involved in 
nervous control of energy balance: arcuate nucleus (ARC), ventromedian (VMH), lateral 
(LH), dorsomedian hypothalamus (DMH) and paraventricular nucleus (PVN). Studied 
genes were CPT1 (carnitine palmitoyl transferase 1), FAS (fatty acid synthase), GPR41 (G 
protein related receptor 41, GPR40 and 43 have been also tested but were not detected in our 
models), ACCǃ (Acetyl carboxylase ǃ) and AMPKǂ2. Results are displayed in figure 5. 
 
Fig. 4. Map of hypothalamic areas involved in nervous control of energy homeostasis. 
Arcuate nucleus (ARC), ventromedian (VMH), lateral (LH), dorsomedian hypothalamus 
(DMH) and paraventricular nucleus (PVN). 
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Hypothalamic gene expression were also modified in some areas depending on FA (figure 
5). For example, FAS expression was inhibited in all nuclei except in VMH of linolenate 




Fig. 5. mRNA expressionof target gene in different hypothalamic areas in oleate or 
linolenate +/- etomoxir. The green line represents gene expression in control rats (infused 
with NaCl). **, p <0.01 vs controls. §§, p <0.01 vs controls. ARC: arcuate nucleus; VMH: 
ventromedian hypothalamus; LH: lateral hypothalamus; DMH: dorsomedian 
hypothalamus; PVN: paraventricular nucleus. 
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In the second serie of experiments, we first measured food intake (figure 6). As depicted, there 
was a decreased in food intake with omegaven and ivelip infusion but not with lard oil. 
 
Fig. 6. Measurement of food intake. *, p<0.05 vs controls, **p<0.01 vs controls. 
Figure 7 depicted time course and area under the curse of glycemia in response to oral 
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Fig. 7. Time course of glycemia (left) and area under the curve of glycemia during oral 
glucose tolerance test (right). **p<0.01, *** p<0.001 vs controls. 
Interestingly, the effect of lard oil was associated with an accumulation of ceramide in the 
hypothalamus (figure 8). Therefore, our data suggest that ceramide accumulation in the 
hypothalamus following icv infusion of saturated fatty acid could contribute to the 
installation of an insulin resistant state by altering nervous output and consequently 
nervous control of insulin secretion and action. 
 
 
Fig. 8. Hypothalamic content of diacylglycerol (DAG) and ceramides in rats infused through 
carotid artery with NaCl (controls), Ivelip, Omegaven or Lard oil during 24h. ***p<0.001 vs 
controls. 
4. Discussion 
It is now clearly evidenced that hypothalamic FA sensing is an important regulator of 
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effects of FA regarding their chain length and degree of saturation. We firstly evidenced 
here that oleate and linolenate have differential effects in regard to glucose homeostasis and 
GIIS. Especially linolenate induced increased GIIS compared to both oleate and control 
group whereas time course of glycemia remained similar. Thus there is a difference between 
effect of monounsaturated and polyunsaturated fatty acids when infused toward the brain. 
This suggest activation of different pathways. It must be pointed out that we previously 
demonstrated that short term infusion of oleate (6h and 24h) induced an increased in insulin 
secretion induced by glucose compared to control rats (Migrenne et al., 2006; Wang et al., 
2006). In the present study infusion was made during 3 days which can explain different 
effect in short vs long term infusion peridod. Indeed we cannot exclude an adaptation to 
oleate effect when infusion stay longer. In the same way of ideas, inhibitory effect of central 
infusion of oleate on food intake was also lost after 3 days of infusion as previously 
evidenced by obici et al (Obici et al., 2002). In contrast, in the present study effect of 
linolenate was still present after 3 days of infusion. Linolenate effect may induce an insulin-
resistance state and increased GIIS could be an adaptation to this insulin resistance state. By 
acting on FA sensitive neurons, linolenate may affect nervous output from CNS, especially 
autonomic nervous system. This change in autonomic nervous system balance will in turn 
modify nervous control of insulin secretion and action. We previously demonstrated that 
lipid infusion induced changes in both sympathetic and parasympathetic nervous activity in 
both rodents (Magnan et al., 1999) and humans (Magnan et al., 2001). In both studies 
decreased sympathetic nervous activity induced an increased insulin secretion in response 
to glucose and insulin resistance. In addition, in the present study we showed that linolenate 
effect involved its metabolism since it had no more effect in presence of etomoxir an 
inhibitor of ǃ oxidation. The involvement of ǃ oxidation to relay FA effect on sensitive 
neurons have been also described in different models by us (Cruciani-Guglielmacci et al., 
2004) and others (Obici et al., 2003). Finally that specific effects of linolenate compared to 
oleate could be, at least in part, related to differential gene transcription involved in FA 
metabolism such as CPT1, FAS or ACC in key areas of hypothalamus. More precisely in 
ARC and LH CPT1 expression was increased in linolenate infused rats and etomoxir 
induced a decreased in this gene and its return to basal value. However, it is difficult to 
further analyze these results since in other nuclei, there is no change of CPT1 expression. In 
addition, in some area others genes are differently expressed such as AMPKǂ2 or ACCǃ, 
both key enzymes of glucose and FA metabolism. Altogether these data suggest that oleate 
or linolenate may act on different subpopulations of neurons (or astrocytes) thus 
highlighting the fact that FAs may have different effect in regard of the area in which they 
act. It is also interesting that expression of gene such as GPR41 can be also modified by 
linolenate infusion. Indeed it has been recently evidenced that short-chain fatty acids and 
ketones directly regulate sympathetic nervous system via GPR41 at the level of sympathetic 
ganglion (Kimura et al., 2011). Thus changes in hypothalamic GRP41 gene expression may 
have an impact during starvation, a situation in which ketone bodies production is 
increased. thereby control body energy expenditure in maintaining metabolic homeostasis. 
In the second part of our work we demonstrated a differential role of PUFA vs saturated FA 
(SFA) regarding induction of insulin resistance and ceramides production in hypothalamus 
by using triglyceride emulsion infusion, in order to mimic a more “physiological approach”. 
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Indeed 24h of lard oil infusion in carotid which had no effect on plasma TG or FA 
concentrations (data not shown) induced a glucose intolerance suggesting a deregulation  of 
insulin sensitivity and or secretion. This deleterious effect of lard oil in nervous control of 
glucose homeostasis was associated with an increased in DAG and ceramides content in 
hypothalamus. An important role for ceramides has emerged from research on the 
pathogenesis of metabolic diseases associated with obesity, such as diabetes (Holland & 
Summers, 2008). Indeed, ceramides appear to be particularly deleterious components of the 
lipid milieu that accrues in obesity, and levels of ceramides are often elevated in skeletal 
muscle, liver, and/or serum of obese humans and rodents (Adams et al., 2004; Clement et 
al., 2002). DAG and ceramides are known to activate kinase such as PKC, which 
phosphorylate insulin receptor substrate and Akt leading to an inhibition of the insulin 
signaling (Mullen et al., 2009; Newton et al., 2009). A recent study also evidenced that 
sphingolipids such as ceramide might be key components of the signaling networks that 
link lipid-induced inflammatory pathways to the antagonism of insulin action that 
contributes to diabetes (Holland et al., 2011). We also recently demonstrated that the 
atypical protein kinase C, PKCΘ, is expressed in discrete neuronal populations of the ARC 
and the dorsal medial hypothalamic nucleus (Benoit et al., 2009). CNS exposure to saturated 
palmitic acid via direct infusion or by oral gavage increased the localization of PKCΘ to 
hypothalamic cell membranes in association impaired hypothalamic insulin and leptin 
signaling (Benoit et al., 2009). This finding was specific for palmitic acid, as the 
monounsaturated FA, OA, neither increased membrane localization of PKCΘ nor reduced 
insulin signaling. Finally, ARC-specific knockdown of PKCΘ attenuated diet-induced 
obesity and improved hypothalamic insulin signaling (Benoit et al., 2009). These results 
suggest that many of the deleterious effects of high fat diets, specifically those enriched with 
palmitic acid, are CNS mediated via PKCΘ activation, resulting in reduced insulin activity. 
Therefore, our data suggest that ceramide accumulation in the hypothalamus following icv 
infusion of saturated fatty acid could contribute to the installation of an insulin resistant 
state by altering nervous output and consequently nervous control of insulin secretion and 
action. 
Further studies are needed to clearly identify molecular mechanism relaying ceramides 
production. However there is now several experiments highlighting some of these 
mechanisms in FA sensitive neurons as described below. 
4.1 Molecular mechanisms involved in neuronal FA sensing 
In FA sensitive neurons, exposure to long chain FA  can alter the activity of a wide variety of 
ion channels including Cl-, GABAA (Tewari et al., 2000), potassium, K+-Ca2+ (Honen et al., 
2003) or calcium channels (Oishi et al., 1990). Additionally, FA inhibit the Na+-K+ ATPase 
pump (Oishi et al., 1990). For example, OA activates ARC POMC neurons by inhibiting 
ATP-sensitive K+ (KATP) channel activity (Jo et al., 2009) and the effect of OA on HGP is 
abolished by icv administration of a KATP channel inhibitor (Jo et al., 2009). However, KATP 
channels are ubiquitously expressed on neurons throughout the brain, not only in FA 
sensing neurons, making the mechanism and site of such in vivo manipulations difficult to 
discern (Dunn-Meynell et al., 1998). Using in vivo and in vitro electrophysiological 
approaches, OA sensitive-neurons have been characterized using whole cell patch clamp 
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records in ARC slices from 14 to 21 day old rats (Wang et al., 2006). Of these 13 % were 
excited by OA and 30% were inhibited by OA (Oomura et al., 1975). The excitatory effects of 
OA appeared to be due to closure of chloride channels leading to membrane depolarization 
and increased action potential frequency (Migrenne et al., 2006). On the other hand, 
inhibitory effect of OA may involve the KATP channels since this inhibition was reversed by 
the KATP channel blocker tolbutamide (Migrenne et al., 2006). Using fura-2 Ca2+ imaging in 
dissociated neurons from the ventromedial hypothalamic nucleus (VMN) neurons, we 
found that  OA excited up to 43% and inhibited up to 29% of all VMN neurons 
independently of glucose concentrations (Le Foll et al., 2009). However, in these neurons, 
inhibition of the KATP channel mediated FA sensing in only a small percentage of FA sensing 
neurons. Importantly, although a relatively large percentage of hypothalamic neurons are 
FA sensors, a select population that also sense glucose are highly dependent upon ambient 
glucose concentrations for the resultant effect of FA on the activity of these neurons (Le Foll 
et al., 2009). Such data suggest that the responses of hypothalamic FA sensitive neurons are 
dependent upon the metabolic state of the animal and thus might be expected to respond 
differently during fasting (when FA levels rise and glucose levels fall) vs. the overfed state 
when glucose levels rise while free FA levels remain relatively unchanged (Le Foll et al., 
2009). However, it must be pointed out that FA are naturally complexed to serum albumin 
in the blood and the concentration of circulating free FA is less than 1% of total FA levels. 
All the studies investigating FA sensing in the hypothalamus either use non-complexed FA 
or cyclodextrin-complexed FA in vitro or in vivo. The concentration of free FA in 
cyclodextrin-complexed FA preparation is unknown. Whether or not the FA concentration 
used mimics FA levels in physiological states needs to be determined. 
4.2 Metabolic-dependent FA sensing effects 
The effects of FA on activity of some neurons are dependent upon intracellular metabolism 
of FA. Enzymes involved in FA metabolism such as FA synthase (FAS), CPT1 and acetyl-
CoA carboxylase (ACC) are expressed in some hypothalamic neurons as well as in glial cells 
(reviewed in (Blouet & Schwartz; Le Foll et al., 2009). Malonyl-CoA may be an important 
sensor of energy levels in the hypothalamus. It is derived from either glucose or FA 
metabolism via the glycolysis or -oxidation, respectively. The steady-state level of malonyl-
CoA is determined by its rate of synthesis catalysed by ACC relative to its rate of turnover 
catalysed by FAS. The synthesis of malonyl-CoA is the first committed step of FA synthesis 
and ACC is the major site of regulation in that process. Thus, when the supply of glucose is 
increased, malonyl CoA levels increase in keeping with a decreased need for FA oxidation. 
This increase in both malonyl CoA and acyl CoA levels is associated with reduced food 
intake. Central administration of C75, an inhibitor of FAS, also increases malonyl-CoA 
concentration in the hypothalamus, suppresses food intake and leads to profound weight 
loss (Proulx & Seeley, 2005). It has been proposed that centrally, C75 and cerulenin (another 
inhibitor of FAS) alter the expression profiles of feeding-related neuropeptides, often 
inhibiting the expression of orexigenic peptides such as neuropeptide Y (Proulx et al., 2008). 
Whether through centrally mediated or peripheral mechanisms, C75 also increases energy 
expenditure, which contributes to weight loss (Clegg et al., 2002; Tu et al., 2005). In vitro and 
in vivo studies demonstrate that at least part of C75's effects are mediated by the 
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modulation of AMP-activated kinase, a known energy-sensing kinase (Ronnett et al., 2005). 
Indeed, icv administration of 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR), a 
5'-AMP kinase activator, rapidly lowers hypothalamic malonyl-CoA concentration and 
increases food intake (Tu et al., 2005). These effects correlate closely with the 
phosphorylation-induced inactivation of ACC, an established target of AMP kinase. 
Collectively, these data suggest a role for FA metabolism in the perception and regulation of 
energy balance. However, it must be also pointed out that C75 and AICAR may also have non-
specific or even opposite effects. For example, a major effect of C75 is to activate CPT-1 rather 
than lead to its inhibition in vitro (Aja et al., 2008). Finally the route of administration and the 
type of FA used are also critical. For example, bolus intracerebroventricular injections of OA, 
but not palmitic acid, reduce food intake and body weight, possibly mediated through 
POMC/MC4R signaling (Schwinkendorf et al., 2010). Again, such bolus icv injections could 
cause non-specific effects related to inflammation of ependymocytes and tanycytes. Also 
because so much of FA metabolism takes place in astrocytes, such manipulations done in vivo 
and in slice preparations are likely to alter FA metabolism that takes place in astrocytes which 
could then indirectly alter neuronal FA sensing (Escartin et al., 2007). 
4.3 Non metabolic-dependent neuronal FA sensing  
While intracellular FA metabolism may be responsible for altering neuronal activity in some 
FA sensitive neurons such as ARC POMC neurons (Jo et al., 2009) it accounts for a relatively 
small percent of the effects of OA on dissociated VMN neurons (Le Foll et al., 2009). In those 
neurons, inhibition of CPT1, reactive oxygen species formation, long-chain acyl CoA 
synthetase and KATP channel activity or activation of uncoupling protein 2 (UCP2) accounts 
for no more than 20% of the excitatory or approximately 40% of the inhibitory effects of OA 
(Le Foll et al., 2009). On the other hand, pharmacological inhibition of FAT/CD36, a FA 
transporter/receptor that can alter cell function independently of intracellular FA 
metabolism reduced the excitatory and inhibitory effects of OA by up to 45% (Le Foll et al., 
2009). Thus, in almost half of VMN FA sensing neurons,  CD36 may act primarily as 
receptor, rather than a transporter, for long chain FA as it does on taste cells on the tongue 
where it activates store-operated calcium channels to alter membrane potential and release 
of serotonin (Gaillard et al., 2008). These effects all occur in the presence of nanomolar 
concentrations of OA, whereas micromolar concentrations are generally required to effect 
similar changes in neuronal activity in brain slice preparations (Jo et al., 2009; Migrenne et 
al., 2011; Wang et al., 2006). Thus, in the absence of astrocytes, OA can directly affect VMN 
neuronal activity through both metabolic and non-metabolic pathways. Alternatively, FA 
might act as signaling molecules by covalent attachment to proteins (N-terminal acylation) 
to alter the function of membrane and intracellular signaling molecules. For example, 
palmitoylation facilitates the targeting and plasma membrane binding of proteins which 
otherwise would remain in the cytosolic compartment (Resh, 1999). Some membrane 
proteins (TGF, synaptosomal associated protein of 25KDa (required for exocytosis) and 
plasma membrane receptors (seven transmembrane receptors such as 2a- and 2-
adrenoceptors) are typically palmitoylated on one or several cysteine residues located 
adjacent to or just within the transmembrane domain (Resh, 1999) Such mechanisms might 
also modulate neuronal FA sensing. 
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4.4 Which neurotransmitters or neuropeptides? 
The ultimate consequence of the activation or inactivation of a neuron is the release of 
neurotransmitters and neuropeptides. Since FA decrease food intake, they might be 
expected to alter activity neurons specifically involved in the regulation of feeding. In fact, 
OA activates catabolic POMC neurons directly, apparently via ß-oxidation and inactivation 
of the KATP channel in hypothalamic slice preparations (Jo et al., 2009). In vivo, Obici et al. 
(Obici et al., 2003) reported that icv administration of OA markedly inhibits glucose 
production and food intake, accompanied by a decrease in the hypothalamic expression of 
the anabolic peptide, neuropeptide Y. This decrease in the expression of such a critical 
anabolic peptide might contribute to the reduced food intake associated with direct central 
administration of OA. On the other hand, an n-3 FA enriched diet increases food intake in 
anorexic tumor-bearing rats, in association with reduced tumor appearance, tumor growth 
and onset of anorexia (Ramos et al., 2005). In these treated rats, neuropeptide Y 
immunoreactivity increased 38% in ARC and 50% in paraventricular nucleus, whereas ǂ-
melanocyte stimulating hormone (a catabolic peptide cleavage product of POMC) decreased 
64% in the ARC and 29% in the paraventricular nucleus (Ramos et al., 2005). Finally, in the 
hippocampus, docosahexaenoic acid (22:6(n-3) increased the spontaneous release of 
acetylcholine (Aid et al., 2005). 
4.5 Pathological implications of excess FA 
Besides physiological regulation of energy balance by hypothalamic neuronal FA sensing, 
impaired regulation of such sensing might contribute to the development of metabolic 
diseases such as obesity and type 2 diabetes in predisposed subjects exposed to a chronic 
lipid overload (Luquet & Magnan, 2009; Migrenne et al., 2011). Excessive brain lipid levels 
may indeed alter control of glucose and lipid homeostasis through changes of autonomic 
nervous system activity. Increasing brain FA levels reduces sympathetic activity and 
increases GIIS in rats (Clement et al., 2002; Obici et al., 2003) a condition which would 
exacerbate the development of type 2 diabetes mellitus. Also, a lipid overload due to high-
fat diet intake alters both hypothalamic monoamine turnover (Levin et al., 1983) and 
peripheral sympathetic activity in rats (Young & Walgren, 1994). In humans, overweight is 
often associated with an altered sympathetic tone (Peterson et al., 1988) suggesting a 
relationship between lipids and autonomic control centers in brain. 
5. Conclusion 
In conclusion, there is now increasing evidence that specialized neurons within 
hypothalamus and other areas such as the brainstem or hippocampus can detect changes in 
plasma FA levels by having FA directly or indirectly alter the of FA sensitive neurons 
involved in the regulation of energy and glucose homeostasis.  Central FA effects on insulin 
secretion and action are related to their chain length or degree of saturation. Such effects are 
also mediated through differential changes in gene expression.  
The neuronal networks of these FA sensitive neurons that sense and respond to FA are 
likely very complex given the fact that FA can either inhibit or excite specific neurons. In 
addition, many of these neurons also utilize glucose as a signaling molecule and there is 
often an inverse responsiveness of such “metabolic sensing” neurons to FA vs. glucose. 
www.intechopen.com
 
Differential Effect of Fatty Acids in Nervous Control of Energy Balance 413 
Thus, these neurons are ideally suited to respond differentially under a variety of metabolic 
conditions such as fasting, feeding, hypo- or hyperglycemia. However, while it is clear that 
specific neurons can respond to changes in ambient FA levels, many questions remain. We 
still do not know for certain how FA are transported into the brain, astrocytes or neurons 
and whether those FA that are transported are derived from circulating free FA or 
triglycerides. Since most studies suggest that rising FA levels reduce food intake, then we 
must explain why plasma FA levels are most elevated during fasting when the drive to seek 
and ingest food should be at its strongest. Another major issue relates to the interaction 
between astrocytes and neurons with regard to the metabolism and signaling of FA. Also, 
we still know little about the basic mechanisms utilized by neurons to sense FA, where such 
FA sensitive neurons reside throughout the brain and what neurotransmitters and peptides 
they release when responding to FA.  
Finally, it has been postulated that diabetes may be a disorder of the brain (Elmquist & 
Marcus, 2003). If so, dysfunction of these FA sensitive neurons could be, at least in part, one 
of the early mechanisms underlying impairment of neural control of energy and glucose 
homeostasis and the development of obesity and type 2 diabetes in predisposed subjects. A 
better understanding of this central nutrient sensing, including both FA and glucose, could 
provide clues for the identification of new therapeutic targets for the prevention and 
treatment of both diabetes and obesity. 
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